What is the management of an asthma attack?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 18, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Asthma Attack

Immediately administer high-dose nebulized salbutamol 5 mg (or terbutaline 10 mg) via oxygen-driven nebulizer AND oral prednisolone 30-60 mg (adults) or 1-2 mg/kg (children, maximum 40 mg) within the first few minutes of presentation, while simultaneously providing supplemental oxygen to maintain SpO₂ >90% (>95% in pregnancy or cardiac disease). 1, 2

Initial Assessment (First 5 Minutes)

Severity classification determines treatment intensity and disposition:

Severe Exacerbation Features 1, 2

  • Cannot complete sentences in one breath
  • Respiratory rate >25 breaths/min (adults) or >50 breaths/min (children)
  • Heart rate >110 beats/min (adults) or >140 beats/min (children)
  • Peak expiratory flow (PEF) <50% of predicted or personal best

Life-Threatening Features Requiring ICU Consideration 1, 2

  • PEF <33% predicted
  • Silent chest, cyanosis, or feeble respiratory effort
  • Altered mental status (confusion, drowsiness, exhaustion)
  • Bradycardia or hypotension
  • Normal or elevated PaCO₂ ≥42 mmHg in a breathless patient

Immediate Treatment Protocol (First Hour)

First-Line Therapy 1, 2, 3

  • Oxygen: 40-60% via face mask to maintain SpO₂ >90% (>95% in pregnancy/cardiac disease)
  • Nebulized salbutamol: 5 mg (or terbutaline 10 mg) via oxygen-driven nebulizer every 20 minutes for 3 doses
    • Alternative: 4-8 puffs via MDI with spacer every 20 minutes for 3 doses
    • Children <15 kg: use half doses (2.5 mg salbutamol)
  • Systemic corticosteroids: Prednisolone 30-60 mg PO (adults) or 1-2 mg/kg PO (children, max 40 mg)
    • If vomiting or critically ill: IV hydrocortisone 200 mg (adults) or 4-7 mg/kg (children)

Add Ipratropium for Moderate-to-Severe Cases 1, 2

  • Ipratropium bromide 0.5 mg added to nebulizer with second and third doses of salbutamol (can be mixed in same nebulizer)
  • Continue every 4-6 hours after initial three doses

Reassessment at 15-30 Minutes 1, 2

Measure PEF, respiratory rate, heart rate, SpO₂, and clinical appearance:

Good Response (PEF >75% predicted) 1

  • Continue usual maintenance therapy with modest step-up
  • Monitor symptoms and PEF on chart
  • Arrange follow-up within 48 hours

Incomplete Response (PEF 50-75% predicted) 1, 2

  • Continue nebulized salbutamol every 4-6 hours
  • Continue oral prednisolone 30-60 mg daily for 5-10 days (no taper needed)
  • Consider hospital admission if severe features persist

Poor Response (PEF <50% predicted or persistent severe features) 1, 2

  • Increase nebulizer frequency to every 15-30 minutes
  • Continue ipratropium every 4-6 hours
  • Arrange immediate hospital admission

Escalation for Refractory Cases 1, 2

If No Improvement After 1 Hour of Intensive Treatment:

  • IV magnesium sulfate 2 g over 20 minutes (adults) or 25-75 mg/kg up to 2 g (children)
  • Consider continuous nebulization of salbutamol
  • IV aminophylline 250 mg over 20 minutes (adults) or 5 mg/kg over 20 minutes followed by 1 mg/kg/h infusion (children)
    • NEVER give bolus aminophylline to patients already on oral theophylline 1

Hospital Admission Criteria 1, 2

Admit immediately if:

  • Any life-threatening features present
  • PEF <33% predicted after treatment
  • PEF <50% predicted after 1-2 hours of intensive treatment
  • Features of severe attack persist after initial treatment
  • Presentation in afternoon/evening with recent nocturnal symptoms
  • Previous severe attacks requiring intubation or ICU admission

ICU Transfer Criteria 1, 2

Transfer accompanied by physician prepared to intubate if:

  • Deteriorating PEF despite therapy
  • Worsening or persistent hypoxia or hypercapnia
  • Exhaustion, feeble respirations, confusion, or drowsiness
  • Impending respiratory arrest

Monitoring Throughout Treatment 1

  • Continuous pulse oximetry maintaining SaO₂ >92%
  • Repeat PEF measurement 15-30 minutes after starting treatment
  • Chart PEF before and after each bronchodilator dose
  • Monitor respiratory rate, heart rate, and clinical appearance continuously

Critical Pitfalls to Avoid 1, 2

  • NEVER administer sedatives of any kind—this is absolutely contraindicated and potentially fatal 1, 2
  • Do NOT delay corticosteroids while "trying bronchodilators first"—both must be given immediately 1, 2
  • Do NOT underestimate severity—always measure PEF or FEV₁ objectively 1
  • Do NOT give bolus aminophylline to patients on oral theophylline 1

Discharge Criteria 1, 2

Patient may be discharged when:

  • PEF ≥70-75% of predicted or personal best
  • PEF diurnal variability <25%
  • Minimal or absent symptoms
  • Stable oxygen saturation on room air for 30-60 minutes after last bronchodilator dose
  • Been on discharge medications for 24 hours

Discharge Requirements 1, 2

  • Verify and document correct inhaler technique
  • Provide written self-management plan with PEF zones
  • Supply peak flow meter if patient doesn't have one
  • Continue oral prednisolone 30-60 mg daily for 5-10 days total (no taper needed for courses <10 days)
  • Initiate or optimize inhaled corticosteroids
  • Arrange primary care follow-up within 1 week
  • Arrange respiratory specialist follow-up within 4 weeks

Special Considerations for Children 1, 4

  • Use half doses (salbutamol 2.5 mg) for children weighing <15 kg 1
  • Prednisolone dosing: 1-2 mg/kg (maximum 40-60 mg) 1, 4
  • Aminophylline should no longer be used in children at home 1
  • Children >5 years can reliably use peak flow meters for monitoring 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Asthma Exacerbation Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Immediate Treatment for Severe Asthma in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What constitutes a smart therapy approach in treating asthma?
What should I do if my asthma patient stops wheezing?
What is the best approach to manage a patient with asthma who presents with fever and cough?
How to manage and prevent daily dry cough in a known asthmatic (Asthma) 20-year-old?
What are the diagnostic criteria and treatment for persistent asthma?
At what age should a 32‑year‑old man with a maternal grandmother diagnosed with colorectal cancer in her 60s and no known paternal family history undergo his first colonoscopy?
In a head‑injured patient, when should mannitol be avoided (e.g., with hypotension, renal impairment, high serum osmolality or sodium, severe pulmonary edema, congestive heart failure, uncontrolled hypertension, allergy, mass lesion risk, or when hypertonic saline is being used)?
What supplement regimen is recommended for adults aged ≥65 years (especially ≥80 years) to correct common deficiencies and avoid excesses?
In a patient with an A1c of 10.2% on basal NPH insulin 30 U daily plus a medium‑dose sliding‑scale of regular insulin, an eGFR of ~67 mL/min/1.73 m², hypertension and prior myocardial infarction, what additional antidiabetic medication should be added?
In a patient with intracranial hemorrhage, should mannitol be used to treat elevated intracranial pressure?
What are the recommended dosing, contraindications, monitoring parameters, common adverse effects, and alternative options for venlafaxine as a first‑line treatment in an adult with major depressive disorder, generalized anxiety disorder, panic disorder, or social anxiety disorder?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.